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ABSTRACT The mechanisms linking deposits of insoluble amyloid ﬁbrils to the debilitating neuronal cell death characteristic of
neurodegenerative diseases remain enigmatic. Recent ﬁndings implicate transiently formed intermediates of mature amyloid
ﬁbrils as the principal toxic agent. Hence, determining which intermediate aggregates represent on-pathway precursors or off-
pathway side branches is critical for understanding amyloid self-assembly, and for devising therapeutic approaches targeting
relevant toxic species. We examined amyloid ﬁbril self-assembly in acidic solutions, using the model protein hen egg-white lyso-
zyme. Combining in situ dynamic light scattering with calibrated atomic-force microscopy, we monitored the nucleation and
growth kinetics of multiple transient aggregate species, and characterized both their morphologies and physical dimensions.
Upon incubation at elevated temperatures, uniformly sized oligomers formed at a constant rate. After a lag period of several
hours, protoﬁbrils spontaneously nucleated. The nucleation kinetics of protoﬁbrils and the tight match of their widths and heights
with those of oligomers imply that protoﬁbrils both nucleated and grew via oligomer fusion. After reaching several hundred nano-
meters in length, protoﬁbrils assembled into mature ﬁbrils. Overall, the amyloid ﬁbril assembly of lysozyme followed a strict hier-
archical aggregation pathway, with amyloid monomers, oligomers, and protoﬁbrils forming on-pathway intermediates for
assembly into successively more complex structures.INTRODUCTION
Alzheimer’s disease and Parkinson’s disease are familiar
representatives of a category of human disorders called
amyloidoses. Amyloidoses are characterized by the deposi-
tion of protein plaques in the extracellular (and sometimes
intracellular) matrix, and extensive tissue damage in the
immediate vicinity of these plaques (1,2). The protein fibrils
forming the scaffold for these extracellular deposits share
a common cross-b-sheet architecture (3,4) that has little
correlation with the native structure of the various proteins
or proteolytic fragments that form these protein fibrils.
Recent studies implicated intermediate aggregates formed
during the assembly of mature fibrils, and not the prominent
protein plaques, as the molecular species mediating cellular
toxicity in amyloidoses (5,6). Understanding the process of
amyloid self-assembly into mature fibrils with a shared
quaternary structure represents a basic challenge in protein
science, and is critical for unraveling the causes of cell death
associated with amyloidoses.
Several distinct aggregate species were clearly identified
as intermediates during amyloid fibril growth, including
small oligomeric species, protofibrils, and mature fibrils
(7). The latter represent the basic building block of large
polymer bundles forming protein plaques (7,8). One
contentious and actively pursued topic in amyloid fibril
growth concerns whether transient aggregates such as olig-
omers and protofibrils represent essential on-pathway
precursors toward mature fibril assembly (9,10) or off-
pathway alternatives to mature fibrils (11), or whether
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in the shared structure of mature fibrils. Part of the diffi-
culty in answering these questions is intrinsic to the very
nature of intermediate aggregates: they represent metastable
and transient states that are in dynamic exchanges with their
monomeric background (14). These difficulties are aggra-
vated by the sensitivity of aggregates sizes and morphol-
ogies to subtle manipulations in solution conditions or
sample preparations (15,16). As a result, the noninvasive
and quantitative characterization of the intrinsic growth
kinetics, sizes, and morphologies of different soluble
amyloid intermediates represents an important step toward
unraveling the elusive relationship between different types
of intermediate aggregates and their role in amyloid fibril
self-assembly.
We combined in situ dynamic light scattering (DLS) with
offline atomic-force microscopy (AFM) for investigating
the amyloid fibrillogenesis of hen egg-white lysozyme
(HEWL). Lysozyme is a small globular enzyme, and is often
used as a model system for studying amyloid fibril formation
(17–19). Variants of human lysozyme were also implicated in
occurrences of hereditary systemic amyloidosis (20). Upon
incubation in acid solutions below pH 4 and at elevated
temperatures, native HEWL will grow amyloid fibrils
(21). A commercial lysozyme stock can be prepared that is
essentially devoid of any preassembled aggregates that can
interfere with intrinsic nucleation and growth behavior (22).
Therefore, HEWL represents an attractive and biomedically
relevant model system for characterizing intermediate
amyloid species, and for investigating their aggregation path-
ways (17).
We place strong emphasis on tight, quantitative correla-
tions between the results obtained with DLS and AFM
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characterization techniques because it is essentially noninva-
sive, is highly sensitive to aggregate formation, and provides
an in situ readout of particle distributions and growth kinetics
(23). These significant advantages of DLS are mitigated by
its limited ability to resolve aggregates whose hydrodynamic
radii Rh differ by less than a factor of 2 or 3. AFM, in
contrast, provides direct images of aggregate morphology
and quantitative measurements of aggregate heights. Using
AFM, however, can be problematic because deposition on
various surfaces has the potential to alter the very aggregate
structures one is trying to characterize (16). In addition,
measurements of lateral (in-plane) aggregate dimensions
are less common because of the dilation of lateral aggregate
dimension by the finite-sized scanning tip.
To address these shortcomings, we calibrated AFM scan-
ning tips, obtaining not just images of aggregate morphol-
ogies but quantitative measures of vertical and lateral
aggregate dimensions. Some of the simpler aggregate geom-
etries characterized using AFM were compared with the
in situ diffusion and growth behavior observed using DLS.
As a result, we were able to make specific statements
regarding the geometries, physical dimensions, assembly
pathways, and nucleation and growth kinetics of lysozyme
oligomers and protofibrils during amyloid fibril growth.
MATERIALS AND METHODS
Protein and chemicals
For all experiments, 2 recrystallized, dialyzed, and lyophilized lysozyme
from Worthington Biochemicals (Lakewood, NJ) was used. All other chem-
icals were from Fisher Scientific (Pittsburgh, PA), and were reagent grade or
better. We used 18 MW distilled water (Barnstead E-pure, Dubuque, IA)
throughout.
Preparation of HEWL amyloid ﬁbrils
Solutions of lysozyme (17 mg/mL) at pH 2.0 with 175 mM NaCl were
prepared by dissolving lyophilized lysozyme in distilled water at twice its
final concentration, and mixing it 1:1 with a NaCl/water solution, also at
twice its final concentration. Before mixing, lysozyme solutions were
warmed to 45C to remove any preformed clusters. All samples were centri-
fuged at 9500  g for 5 min, and filtered consecutively through a 220-nm
and a 20-nm pore-size syringe filter. Solution pH was readjusted to pH
2.0 with 1 N HCl. Lysozyme concentrations in solution were determined
from ultraviolet absorption measured at l ¼ 280 nm (a280 ¼ 2.64 mL
mg1 cm1) (24). Lysozyme solutions incubated for 4–5 days at 50C
started to form a soft gel. Fibers taken from the gelled-out samples induced
a red shift in the absorption spectrum of Congo red, a feature diagnostic for
the formation of mature amyloid fibrils. Samples analyzed before ~3 days of
incubation all showed a much weaker spectral shift, identical in magnitude
to the nonspecific shift induced by lysozyme monomers (data not shown).
DLS during amyloid aggregation
DLS measurements were performed with a Zetasizer Nano S (Malvern
Instruments, Worchestershire, UK) containing a 3-mW He-Ne laser (l ¼
633 nm) and with built-in temperature control for sample cuvettes. After
thermal equilibration of the samples (typically < 5 min), autocorrelationBiophysical Journal 96(9) 3781–3790functions were collected every 10 min, using acquisition times of 60 s. Auto-
correlation functions were converted into particle-size distributions, using
the ‘‘narrow modes’’ algorithm provided with the Zetasizer Nano S.
Particle-size distributions obtained from alternative inversion algorithms
yielded comparable results.
AFM of amyloid aggregates
Amyloid samples were imaged with an MFP-3D atomic-force microscope
(Asylum Research, Santa Barbara, CA) using NSC36/NoAl (Mikromasch,
San Jose, CA) or PFP-FMR-50 (Nanosensor, Neuchatel, Switzerland)
silicon tips with nominal tip radii of 10 nm and 7 nm, respectively. The canti-
lever was driven at 60–70 kHz in alternating current mode and a scan rate of
0.5 Hz, acquiring images at a 1024  1024-pixel resolution. Raw image data
were corrected for image bow and slope.
During DLS measurements of amyloid fibrillogenesis, 10-mL aliquots of
solution were taken from the DLS cuvette for subsequent AFM imaging.
Aliquots were diluted 100-fold with 175 mM NaCl/pH 2.0 salt solutions.
Typically, 75 mL of solution were deposited on freshly cleaved mica for
5 min, rinsed with deionized water, and dried with dry nitrogen. Images
of monomers required significantly longer deposition periods (R15 min),
apparently because their surface affinity and/or deposition kinetics onto
mica are significantly lower than those of higher-order aggregates. These
differences presumably account for the apparent lack of monomers and/or
oligomers after protofibril formation. Images of amyloid aggregates were
acquired in air. Using DLS, we confirmed that cooling the lysozyme samples
from 50C to room temperature essentially arrested aggregation (data not
shown). Hence, AFM images faithfully represented the aggregate distribu-
tion at the time of aliquot collection.
AFM tip calibration and correction for tip dilation
The AFM tip radii were determined by imaging 5-nm gold colloid standards
(catalogue No. GC5; BBI International, Cardiff, UK). Poly-d-lysine (1%)
was deposited onto freshly cleaved mica for 10 s, rinsed with deionized
water, and dried with nitrogen. The gold colloids were diluted 1:20 with de-
ionized water and deposited for 1 min, rinsed with deionized water, and
dried with nitrogen. As indicated in Fig. 1, the apparent width Wapp of an
incompressible object imaged with an AFM tip is considerably larger than
its physical width W. Apparent width Wapp and height for a given gold
colloid were determined from individual scan lines across the maximal
height of a given gold colloid. Following Taatjes et al. (25), the apparent
FIGURE 1 Dilation of lateral particle dimension during AFM imaging.
Finite size of AFM scanning tips (shown here as parabola) increases
apparent width Wapp of particles well beyond their actual width W. For an
ellipse, W can be derived using the measured height H and Wapp of the
particle and the tip radius Rt (25).
Protoﬁbril Nucleation and Growth 3783FIGURE 2 Kinetics of fibril formation by HEWL, monitored in situ with
DLS. (A) Temporal evolution of field autocorrelation functions g1(t) of light
scattered from HEWL solutions during amyloid fibrillogenesis at pH 2.0 and
T ¼ 50C. After a latency period of ~10 h, a prominent shoulder of slower
decay rates emerges in correlation functions. (B) Semilog plot of PSDswidth Wapp and height of a sphere were used to obtain the radius Rt of the
scanning tip. Assessed according to measured heights, the radii of individual
gold colloids will vary slightly. Therefore, we determined the radius Rt using
a series of gold colloids. This approach yielded reproducible and self-consis-
tent values for Rt. Repeating tip calibrations during extended imaging
sessions on mica substrates indicated that tip radii remained unaltered.
To correct for the dilation in apparent particle width induced by scanning
tips (Fig. 1), line profiles of apparent particle width versus height were taken
across the center of a given particle. The direction for these line profiles was
typically chosen as perpendicular to the scanning direction of the AFM tip
during image acquisition. The shape of profiles was highly symmetric
around the peak height, suggesting that mechanical tip distortions were
small. Assuming that aggregates had ellipsoidal cross sections, and using
the AFM tip radius determined during tip calibration, the actual particle
width was calculated (25).
Prediction of hydrodynamic radii
from AFM particle dimensions
Particle dimensions for lysozyme monomers and oligomers were extracted
from AFM line scans. The formula of Perrin (26) predicts the hydrodynamic
radius for a sphere diffusing at the same rate. For an oblate ellipsoid with
major axis a and minor axis b, the hydrodynamic radius is given by Perrin
(26) as:
Rh ¼ b x=tan1ðxÞ; where xh
ða=bÞ211=2: (1)
Similarly, the straight protofibrils present shortly after nucleation were
approximated as cylindrical rods. The effective hydrodynamic radius for
a cylinder of length L and diameter d is given by
Rh ¼ L=2
h
1  x21=2=ln

1 þ 1  x21=2

=x
i
;
where xhd=L½1 þ 0:37ðL dÞ=L: ð2Þ
RESULTS
In situ DLS measurements of aggregate
distributions and growth kinetics
DLS is a minimally invasive technique for detecting and
characterizing submicron aggregates in situ, and with high
temporal resolution. These are distinct advantages when
trying to resolve the growth kinetics of multiple aggregate
species that are in dynamic equilibrium with one another.
Fig. 2 A shows the temporal evolution of the field correlation
functions g1(t) of light scattered during the fibril formation
of HEWL at pH 2.0 over a period of 4 days. After a nearly
single-exponential decay of g1(t) for DLS measurements
during the initial 10 h of incubation, g1(t) suddenly devel-
oped a prominent shoulder. This shoulder indicates the
formation of a second population of larger aggregates,
derived from correlation functions in A. Initially, the PSD has a single,
narrow, ‘‘small-aggregate’’ peak. After a lag period of several hours,
a second ‘‘large-aggregate’’ peak emerges and starts to dominate PSDs.
(C) Log-log plot of center position of two aggregate peaks in B as a function
of incubation period. Note nucleation and gradual growth of larger aggregate
peak. (D) Log-log plot of changes in static scattering intensity Iscat versus
incubation period. Intensity values were corrected for changes in laser atten-
uation used to avoid detector saturation.Biophysical Journal 96(9) 3781–3790
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increasing amplitude of this shoulder and its steadily
decreasing decay rate suggest that both the sizes and
numbers of these larger aggregates are increasing in time.
Particle size distributions (PSDs) were derived from the
measured correlation function by analyzing their underlying
distribution of decay rates (detailed in Materials and
Methods). The PSDs thus obtained contained, at most, two
aggregate peaks with well-separated hydrodynamic radii,
which we refer to as ‘‘small-aggregate’’ and ‘‘large-aggre-
gate’’ peaks (Fig. 2 B). During initial stages of incubation,
the small-aggregate peak, with a distribution centered near
a hydrodynamic radius Rh of 2 nm, was dominant. The
larger-aggregate species emerged after a sample-specific
latency period of several hours, with its initial Rh ~25 nm.
After the appearance of the large-aggregate peak, the
small-aggregate peak began to fade slowly. Fig. 2 C shows
the temporal evolution of the mean radius for either of these
two aggregate populations. The mean radius of the small-
aggregate peak appears to be essentially stationary (but see
Results for comparisons of DLS with AFM data), whereas
larger aggregates increase their mean radius slowly but
steadily over the course of 2 days. Fig. 2 D displays the cor-
responding changes in static scattering intensity as a function
of time. The nucleation event of the large-aggregate peak
seen in Fig. 2 C leads to an accelerating growth in scattering
intensity. At the end of the 4-day period, the total scattering
intensity has increased nearly 100-fold above its value at the
beginning of the experiment. This latter observation has two
implications. First, one must be careful interpreting the
apparent ‘‘loss’’ of small aggregates from the particle-size
distribution observed after ~2 days of incubation (Fig. 2, B
and C). This loss is attributable, at least in part, to the rapid
rise in scattering signal from the larger aggregates, which
overwhelms residual scattering contributions from smaller
aggregates. Second, the nearly 100-fold increase in scat-
tering intensity (Fig. 2 D) is in marked contrast to the very
modest twofold increase in mean hydrodynamic radius of
the large-aggregate species over the same 2–3 days
(Fig. 2 C). This behavior puts significant constraints on
any kinetic model of aggregate growth in this system.
Aside from the expected variations in the latency period of
nucleation, all of the above features of DLS data were remark-
ably reproducible (Ntotal ¼ 12), indicating that they capture
the intrinsic behavior of lysozyme amyloid growth in acidic
solutions. The observed evolution of PSDs and corresponding
changes in scattering intensity provide detailed information
about the kinetics of aggregate nucleation and growth.
However, the DLS data also contain several ambiguities
that prevented a more detailed analysis. In particular, it was
unclear whether either the small-aggregate or large-aggregate
peaks in Fig. 2 B were composed of multiple distinct aggre-
gate species not resolved into separate components by DLS.
In addition, the identity of intermediate aggregates under-
going nucleation from solution remained uncertain. Finally,Biophysical Journal 96(9) 3781–3790no specific information was provided about the morphology
of any of the intermediate aggregate species comprising either
aggregate peak. To address these shortcomings, we per-
formed offline AFM on samples undergoing fibril formation.
Ofﬂine AFM measurements of aggregate
morphologies and their dimensions
To correlate AFM data with DLS measurements, lysozyme
fibrillogenesis was monitored using DLS while small
aliquots were withdrawn for AFM imaging at various times
during the incubation period. Before AFM measurements,
the radii of all AFM scanning tips were calibrated against
colloidal gold standards. As detailed in Materials and
Methods, this enabled us to derive not just aggregate height
distributions, but also lateral aggregate dimensions.
The AFM images of lysozyme before heating yielded
uniform particles well approximated by oblate ellipsoids,
with dimensions of 3.0  0.2 nm in height and 3.8  0.8 nm
in equatorial width (Fig. 3 A and Table 1). Because their
volume of 22.6 nm3 is in close agreement with the volume
of 21.2 nm3 for lysozyme monomers in crystals (27), we iden-
tified these particles as lysozyme monomers. The aspect ratio
of surface-absorbed lysozyme monomers was only slightly
different from that of their counterparts in solution (28). After
raising sample temperatures to 50C, solutions contained
mixtures of lysozyme monomers and compact elliptical
aggregates with narrow size distributions (Fig. 3 B). We refer
to these small, compact aggregates as oligomers. Our AFM
observations thus imply that the seemingly uniform small-
aggregate peak observed with DLS was indeed composed
of lysozyme monomers, combined with an increasing number
of oligomers that formed upon sample heating. Oligomer
dimensions, determined by AFM at different times, remained
constant. The ratios of apparent widths versus heights ob-
tained using AFM were not consistent with the assumption
of spherical geometries for either oligomers or monomers,
but did match those expected for oblate ellipsoids. Based on
this ellipsoidal geometry, the volume of oligomers was esti-
mated at 8.1 times that of a lysozyme monomer, suggesting
that oligomers are composed of eight monomers.
The prominent nucleation of larger aggregates detected by
DLS (Fig. 2 C) coincides with the appearance of short, cylin-
drical polymers in AFM images (Fig. 3 C). We identify this
polymeric species as protofibrils, consistent with previous
AFM assignments of intermediate aggregate morphologies
observed with beta-amyloid (Ab)1-40 (29). During the
2–3-day growth period after nucleation, the contour length
of protofibrils increases significantly (Fig. 3 D). The increase
in protofibril contour length goes hand-in-hand with a signif-
icant increase in the curvature of protofibril strands. This
transition from straight to highly curved morphologies is
particularly apparent when comparing late-stage protofibril
shapes (Fig. 3, D and E) with the short, straight protofibrils
present shortly after nucleation (Fig. 3 C).
Protoﬁbril Nucleation and Growth 3785FIGURE 3 AFM images of intermediate amyloid aggregates formed by lysozyme. Evolution of aggregate morphologies for lysozyme amyloid growth at
pH 2.0 and T ¼ 50C. (A) Before heating (T ¼ 20C), a uniform population of HEWL monomers is present. (B) AFM images of HEWL samples after 3 h of
incubation at 50C predominately yield oligomers. (C) AFM image of protofibrils appearing ~10 h, i.e., shortly after nucleation event seen in DLS. (D) AFM
image of protofibrils after 25 h of incubation. (E) AFM image of long, straight fibrils formed after ~100 h of incubation, against a background of protofibrils
(note change in scale-bar dimension). Below each image is the distribution of aggregate heights and lateral aggregate widths (the latter corrected for AFM tip
distortions). Apparent difference in oligomer size in B versus protofibril width in C highlights effect of AFM scanning tips (16 nm in A and B versus 12.5 nm in
C–E) on lateral aggregate dimensions. Tip-corrected aggregate dimensions are identical (see Fig. 5 and Table 1).The AFM images of protofibrils reveal several intriguing
features. First of all, protofibrils have noticeable and rather
regular height undulations. In principle, this variegated
appearance is compatible with the presumption that any
polymeric precursor of mature fibrils already displays the
helical twists known to exist in mature fibrils (3). However,
our calibrated AFM measurements of aggregate dimensions
indicate that protofibril heights and width are identical to
those of oligomers seen before protofibril nucleation (Table 1
and Fig. 4). Fig. 5 gives a comparison of the three-dimen-
sional profile of an oligomer versus the corresponding
appearance of a short protofibril, both visualized with
AFM using identical scanning tips. The height undulations
TABLE 1 Heights and actual widths of amyloid aggregates
Sample Height (nm) Actual width (nm)
Monomer (0 h) 3.0  0.2 3.8  0.8
Oligomer (3 h) 3.9  0.1 9.5  1.0
Protofibril (10.5 h) 3.9  0.3 9.5  1.7
Protofibril (55 h) 3.9  0.2 9.6  1.0
Mature Fibril (100 h) 6.0  0.2 13.9  1.0
Averages of heights and actual widths for various intermediate aggregates
formed during HEWL fibrillogenesis were obtained using AFM.(Fig. 5 B), combined with the tight agreement of the protofi-
bril cross section with the overall height and width of oligo-
mers (Figs. 4 and 5), indicate that protofibrils are composed
of oligomers. The appearance of well-distinguished ‘‘blobs’’
with dimensions very close to those of oligomers suggests
how oligomers coalesce to form protofibrils: oligomers
fuse along their high-curvature perimeter, forming strings
of aggregates similar to hockey pucks lining up edge to
edge on a flat surface.
During the late stages of our experiments, a second,
distinct population of fibers emerged. These mature fibrils
are much longer and stiffer than those of the shorter protofi-
brils (Fig. 3 E). A direct comparison of mature fibril cross
sections with those of protofibrils (Fig. 4) indicates that the
former are ~1.5 times as high and wide as protofibrils.
Both the radius of curvature of mature fibrils and their over-
all length are dramatically increased over those of protofi-
brils (Fig. 3 E). This dramatic increase in persistence length
indicates that mature fibrils are mechanically much stiffer
than protofibrils. Although we did not analyze this feature
quantitatively, it is again in good qualitative agreement
with AFM images of Ab1-40 protofibrils versus mature
fibrils (e.g., Fig. 1 in Koo et al. (29)). Distributions ofBiophysical Journal 96(9) 3781–3790
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dilation) of all intermediate amyloid aggregates are summa-
rized in Fig. 4 and Table 1.
Quantitative comparison of DLS with AFM
aggregate dimension
As alluded to in the Introduction, any offline analysis of
intermediate amyloid aggregates carries the potential risk
of disrupting some of the aggregate features it is intended
to characterize. With AFM, the morphology of amyloid
aggregates can depend on the properties of the substrate
used for deposition or growth (16). It is also not obvious
whether the sizes and shapes of amyloid aggregates in solu-
tion should match those that were dried and deposited on
mica substrates. We therefore tested whether aggregate
shapes and sizes obtained from offline AFM scans with cali-
brated tip sizes matched corresponding hydrodynamic radii
obtained from in situ DLS. For comparisons of particle
FIGURE 4 Dimensions of intermediate amyloid aggregates. Summary of
heights and widths of lysozyme monomers, oligomers, protofibrils, and
mature fibrils obtained from AFM images after tip correction. Ellipses are
scale representations of measured cross sections.Biophysical Journal 96(9) 3781–3790dimension we chose monomers, oligomers, and early-stage
protofibrils. Monomers and oligomers were suitable, because
their shapes can be closely approximated by oblate ellip-
soids, and their sizes did not change over time. Similarly,
the geometry of early-stage protofibrils (Fig. 3 C) were
well represented by cylindrical rods with an initial length
of 125  28 nm and a diameter of ~6 nm. Using Perrin’s
formulas (see Materials and Methods and Perrin (30) allowed
us to calculate the hydrodynamic radius of an equivalent
sphere with the same (translational) diffusion constant as
an oblate ellipsoid or a long, thin cylinder. Table 2 summa-
rizes these equivalent hydrodynamic radii for lysozyme
monomers, oligomers, and initially rod-like protofibrils, as
predicted from their dry-aggregate dimensions (AFM) versus
measured average hydrodynamic radii (DLS). Given our
simplifying assumptions about particle geometry, the neglect
of hydration layers, and the potential for particle distortions
from AFM tips of surface adhesion, the hydrodynamic radii
of monomers and protofibrils predicted from AFM measure-
ments matched surprisingly well with measured DLS radii
for either population. The DLS radius for oligomers deserves
further comment. The less than twofold difference in hydro-
dynamic radii for oligomers versus monomers, as predicted
by AFM, is below the resolution limit typical for DLS.
Hence DLS could not separate the small aggregate peak
into its two components. The ‘‘oligomer’’ radius reported
in Table 2 is really the average of monomers and oligomers,
weighted by their respective scattering intensities. This inter-
pretation is also supported by subtle changes to the shape of
the ‘‘small-aggregate peak’’ during the early stages of nucle-
ation (Fig. 6 A). As time passes, the narrow PSD peak
TABLE 2 Comparison of measured (DLS) and estimated (AFM)
hydrodynamic radii of intermediate aggregates
Sample DLS Rh (nm) AFM Rh (nm)
Monomer (0 h) 1.9 1.8  0.3
Oligomer (3 h) 2.3* 3.8  0.4
Protofibril (10.5 h) 21.6 18.2  3.0
DLS Rh (nm), measured hydrodynamic radii for lysoyzme monomers (0 h),
weighted averages of monomers and oligomers (3 h), and protofibrils shortly
after nucleation (10.5 h). AFM Rh (nm), predicted hydrodynamic radii for
lysozyme monomers, oligomers, and protofibrils, based on AFM dimen-
sions.
*DLS ‘‘oligomer radius’’ is average of monomers and oligomer radius,
weighted by scattering intensity for each species present at 3 h.FIGURE 5 AFM surface topography of oligomers and
protofibrils. (A) AFM topography of a HEWL oligomer
after 3 h of incubation at 50C. (B) AFM topography of
HEWL protofibrils shortly after nucleation event. Both
images were collected with same scanning tip, but aggre-
gate dimensions were not corrected for dilation in x-y
plane. Images are 125 nm on a side.
Protoﬁbril Nucleation and Growth 3787progressively broadens with time, because of the formation
of an increasing number of oligomers.
The above analysis indicates that, whenever a direct
comparison was feasible, the dimensions of intermediate
aggregates derived from calibrated AFM measurements
were consistent with corresponding in situ measurements ob-
tained with DLS. Hence, we felt assured that conclusions
about aggregate morphologies and dimensions derived
from offline AFM observations accurately represented the
in situ behavior of aggregates during growth in solution.
Conversely, we used our a priori knowledge of aggregate
morphologies derived from AFM imaging to reduce the
ambiguities intrinsic to the inversion of DLS decay rates
into particle-size distributions. Specifically, AFM indicates
that, before protofibril nucleation, the solutions are mixtures
FIGURE 6 Analysis of oligomer formation in DLS. (A) PSD of ‘‘small-
aggregate peak’’ before protofibril nucleation becomes increasingly skewed,
with its center position shifting slightly. These changes coincide with growth
of uniformly sized oligomers seen in AFM (Fig. 3 B). (B) Changes in mean
hydrodynamic radius <Rh> obtained from double-exponential fits to DLS
autocorrelation functions during initial 3 h of oligomer growth.of monomers and oligomers, each with fixed hydrodynamic
radii. Therefore, we directly fit the field correlation functions
g1(t) to double exponentials, with decay rates set to the pre-
determined monomer and oligomer radii. Residual errors for
this double-exponential fit (without adjustable parameters)
were significantly reduced over comparable fits to single
exponentials with adjustable decay rates. Using this
approach, we found that the mean hydrodynamic radius
<Rh> increases linearly during the first 3 h of oligomer
growth (Fig. 6 B). Thus the rate of oligomer formation during
the lag phase is essentially constant.
DISCUSSION
Clearly, lysozyme fibril formation shares many similarities
with the aggregation kinetics and aggregate morphologies
of the Alzheimer amyloid peptide Ab1-40. For example,
the relative sizes and appearance of lysozyme protofibrils
and double-stranded fibrils (Fig. 3 E) closely match AFM
images of comparable Ab1-40 samples (29). Similarly, the
reported growth kinetics of protofibrils are highly reminiscent
of kinetic data obtained from Ab1-40 fibrils grown in acidic
solutions (31). These similarities support the idea that impor-
tant aspects of amyloid fibrillogenesis are shared among many
different types of amyloid proteins, including the formation of
oligomeric species, the formation of both oligomers and pro-
tofibrils before the emergence of mature fibrils, and the shared
cross-b-sheet structure of mature fibrils (32).
Aside from these similarities, the data indicate that lyso-
zyme offers distinct advantages as a model system for
studying critical aspects of amyloid-aggregation kinetics.
One such advantage is the control over the rate of aggrega-
tion via simple experimental interventions, such as changes
in solution pH or temperature. As a result, we were able to
retard protofibril nucleation sufficiently to open up an exper-
imental window of several hours for studying the intrinsic
growth kinetics of oligomer formation, unobstructed by
interference from other aggregate species (Fig. 2 C). Simi-
larly, the separation of early stages of oligomer formation
from the nucleation and subsequent growth of protofibrils
permitted us to analyze how oligomer formation is coupled
to protofibril nucleation and growth. In addition, correlating
in situ DLS data with calibrated AFM measurements of
aggregate dimension during the same experiment qualita-
tively improved the range of conclusions that could be
derived from these data sets.
Solution morphology and growth kinetics
of oligomers
Before protofibril nucleation, AFM images indicate the pres-
ence of oligomeric lysozyme aggregates with very narrow
size distributions and a volume equivalent to eight mono-
mers. The AFM dimensions of these oligomers (Fig. 4 and
Table 1) are consistent with oblate ellipsoids of 3.9-nmBiophysical Journal 96(9) 3781–3790
3788 Hill et al.height and a 9.5-nm equatorial diameter. The hydrodynamic
radius for the equivalent sphere of only 3.8 nm naturally
accounts for the difficulties of separating the small-aggregate
peak in DLS into separate monomer and oligomer peaks.
Using the a priori knowledge of oligomer geometry enabled
us to analyze DLS correlation functions as a simple superpo-
sition of only two decay components, with decay rates
matching those for monomers and oligomers. More impor-
tantly, the self-consistency between AFM aggregate dimen-
sions and corresponding bimodal fits to the DLS data
indicated that the oligomer shapes and dimensions derived
using AFM closely approximated the actual oligomer
conformation in solution. The correlation functions before
protofibril nucleation also indicated that the average hydro-
dynamic radius of a small-aggregate peak increases linearly
with incubation period (Fig. 6 B). Combined with the
constant size of oligomers seen in AFM (Fig. 3 B), this
observation indicates that oligomer formation initially
proceeds at an essentially constant rate.
Nucleation and growth of protoﬁbrils from
oligomers
Aside from opening up a window on the intrinsic growth
kinetics of oligomers, the DLS data also clearly resolve
a prominent nucleation event (Fig. 2 C). The concurrent
emergence of short protofibrils seen in AFM identifies
them as the aggregate species undergoing nucleation-limited
growth. As indicated in the Introduction, there are conflicting
results regarding the nucleation and growth process of proto-
fibrils. The correlated DLS and AFM measurements indicate
that lysozyme protofibrils both nucleate and grow from olig-
omers. Evidence for this conclusion is provided by both the
kinetic data on protofibril nucleation from DLS, and by
comparisons of protofibril cross sections with oligomer
dimensions obtained using AFM. First, the presence of
a well-defined nucleation event (DLS) and the identification
of the nucleating species as protofibrils (AFM) established
that protofibrils undergo nucleation-limited growth. Multiple
scenarios have been proposed to explain how protofibril
nucleation and growth are linked to amyloid monomers
and/or oligomers. It has been suggested that protofibrils
grow via monomer addition, with oligomers only acting as
(heterogeneous?) nucleation sites lowering the nucleation
barrier. The DLS and AFM data on lysozyme indicate,
instead, that oligomer formation commences without delay
upon heating the solutions (Fig. 6 B), whereas protofibrils
nucleation is delayed by several hours. The model of oligo-
mers as nucleation sites, in contrast, implies that protofibril
nucleation begins in lock-step with oligomer formation.
Alternately, oligomers and protofibrils might both grow
directly from monomers, but along competing aggregation
pathways. In this scenario, oligomers would initially grow
from monomers. Protofibril formation would be delayed by
the need to form a seed. After protofibril nucleation,Biophysical Journal 96(9) 3781–3790however, they would start to compete with oligomers for
the same pool of monomeric growth units. The kinetic data
per se obtained via DLS cannot readily distinguish between
the growth of oligomers and protofibrils from monomers
along competing pathways versus the on-pathway growth
of oligomers leading up to the nucleation and growth of pro-
tofibrils. However, the quantitative agreement between the
AFM cross sections of protofibrils with the overall dimen-
sions of oligomers (Table 1 and Figs. 4 and 5) strongly
argues in favor of oligomers as the basic nucleation and
growth unit for protofibrils, and against off-pathway olig-
omer formation. This further implies that oligomer formation
represents the rate-limiting step for the nucleation and
growth of protofibrils.
Protoﬁbril elongation and self-assembly
into mature ﬁbrils
Closer inspections of AFM images of short protofibrils, i.e.,
those observed soon after nucleation, suggest how oligomers
come together to form protofibrils. Oligomers appear to coa-
lesce into linear aggregates along their highly curved perim-
eters, reminiscent of hockey pucks lining up along a surface.
This model appears rather distinct from predictions of proto-
fibrils with spiral geometries (33) that resemble the helical
structures observed for mature fibrils with fully developed
cross-b-sheet structures (3,34).
As the overall contour length of protofibrils increases,
their morphology changes from short cylindrical rods to
curvilinear polymer chains. We presume that this switch in
protofibril morphology is a direct consequence of the short
persistence length for protofibril polymers. We cannot rule
out, however, that the observed changes in the morphology
of protofibrils reflect concomitant changes in their internal
structure. The transition from initially straight to highly
curved protofibril geometries can also account for the
apparent discrepancy between the very modest increase in
the hydrodynamic radius of protofibrils (Fig. 2 C) versus
the rather dramatic increase in scattering intensity (Fig. 2 D)
during ~3.5 days of growth. Because the radius of gyration
for random Gaussian coils grows with the square root of
the coil’s contour length, the hydrodynamic radius would
be expected to increases only slowly with the molecular
weight of the protofibrils, whereas the scattering intensity
would increase with roughly the square of the aggregate’s
molecular weight.
The short persistence length of protofibrils compared with
the stiffness of mature fibrils (Fig. 3 E) further reinforces our
assertion that protofibrils do not yet posses the helical cross-
b-sheet structure of mature fibrils. Although the increase in
diameter of mature fibrils over protofibrils should increase
their stiffness, the modest 1.5-times difference in cross
sections seems insufficient to account for the dramatic
increase in stiffness from protofibrils to mature fibrils. We
presume, instead, that the difference in mechanical stiffness
Protoﬁbril Nucleation and Growth 3789arises from the distinct internal organization of protofibrils
versus mature fibrils. Macromolecular assemblies with
a helical organization, such as mature amyloid fibrils, tend
to be mechanically stiff. The large persistence length of
double-stranded DNA provides a classical example of this
behavior. The long, straight shapes of double-stranded fibrils
match the expected relationship between helical structure
and mechanical stiffness. Protofibrils, in contrast, seem to
lack such mechanical stiffness.
Linear, hierarchical assembly pathway
In summary, under acid growth conditions, lysozyme amyloid
growth proceeded along a clearly defined and hierarchical
aggregation pathway. Amyloid monomers aggregated into
small oligomers of uniform size, without any apparent nucle-
ation barrier. The population of these oligomers increased
steadily throughout the lag period before protofibril nucle-
ation. After increasing to some critical threshold concentra-
tion, protofibril nucleation commenced. Protofibrils grew as
polymeric aggregates of oligomers, with oligomers adding
to the ends of protofibrils. The agreement between the heights
and widths of protofibrils and oligomers indicates that lyso-
zyme oligomers coalesce along their highly curved perimeter
when forming protofibrils. It also indicates that protofibrils do
not yet share the helically twisted structure of mature fibrils (4).
After reaching a contour length of few hundred nanometers,
protofibrils then appeared to self-assemble into much longer
and stiffer mature fibrils.
Our results regarding correlated AFM and DLS measure-
ments suggest that lysozyme amyloid fibril formation at
acid pH values provides a favorable model system for detailed
analyses of the nucleation and growth kinetics of intermediate
amyloid aggregates. The well-characterized structure of lyso-
zyme monomers, the ease of controlling aggregation kinetics,
the clear separation of oligomer formation from subsequent
growth steps, and the ability to perform in situ characteriza-
tion of aggregation kinetics are advantages that would be diffi-
cult to achieve with many other amyloid proteins and
peptides. Such control provides significant advantages when
trying to unravel the multifaceted interplay between various
intermediate aggregates species, how they depend on their
internal structure, how they respond to various interventions,
and how they relate to cellular toxicity.
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